[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1112254A1 - Method of producing protein by using hamster igf-1 - Google Patents

Method of producing protein by using hamster igf-1

Info

Publication number
HK1112254A1
HK1112254A1 HK08107585.8A HK08107585A HK1112254A1 HK 1112254 A1 HK1112254 A1 HK 1112254A1 HK 08107585 A HK08107585 A HK 08107585A HK 1112254 A1 HK1112254 A1 HK 1112254A1
Authority
HK
Hong Kong
Prior art keywords
producing protein
hamster igf
igf
hamster
protein
Prior art date
Application number
HK08107585.8A
Other languages
English (en)
Inventor
Hisahiro Tabuchi
Saeko Tanaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1112254A1 publication Critical patent/HK1112254A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
HK08107585.8A 2005-02-21 2008-07-10 Method of producing protein by using hamster igf-1 HK1112254A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005044625 2005-02-21
JP2005275485 2005-09-22
PCT/JP2006/303045 WO2006088198A1 (ja) 2005-02-21 2006-02-21 ハムスターigf-1を用いたタンパク質の製造方法

Publications (1)

Publication Number Publication Date
HK1112254A1 true HK1112254A1 (en) 2008-08-29

Family

ID=36916594

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107585.8A HK1112254A1 (en) 2005-02-21 2008-07-10 Method of producing protein by using hamster igf-1

Country Status (11)

Country Link
US (1) US8062863B2 (xx)
EP (2) EP2172480B1 (xx)
JP (1) JP4999677B2 (xx)
KR (1) KR101273001B1 (xx)
CN (1) CN101151276B (xx)
AU (1) AU2006215012B8 (xx)
CA (1) CA2598570C (xx)
HK (1) HK1112254A1 (xx)
SG (1) SG174827A1 (xx)
TW (1) TWI406870B (xx)
WO (1) WO2006088198A1 (xx)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0346429B1 (en) * 1987-12-24 1994-12-28 Gropep Pty. Ltd. Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
ATE300615T1 (de) 1990-08-29 2005-08-15 Genpharm Int Transgene mäuse fähig zur produktion heterologer antikörper
WO1993002227A1 (en) 1991-07-15 1993-02-04 Eco-Tec Limited Process and apparatus for treating fluoride containing acid solutions
AU675661B2 (en) 1992-07-24 1997-02-13 Abgenix, Inc. Generation of xenogeneic antibodies
US5285485A (en) 1993-02-01 1994-02-08 General Electric Company Composite nuclear fuel container and method for producing same
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
EP0822830B1 (en) 1995-04-27 2008-04-02 Amgen Fremont Inc. Human anti-IL-8 antibodies, derived from immunized xenomice
CA2219486A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
AUPN442295A0 (en) * 1995-07-26 1995-08-17 Commonwealth Scientific And Industrial Research Organisation Regulated autocrine growth of mammalian cells
WO2000040613A1 (en) 1999-01-06 2000-07-13 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
ES2329220T3 (es) * 1999-01-06 2009-11-24 Genentech, Inc. Variantes mutantes del factor de crecimiento similar a insulina (igf) i.
US7469185B2 (en) * 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
CA2565987A1 (en) * 2004-05-11 2005-11-24 Wyeth Oligonucleotide arrays to monitor gene expression and methods for making and using same

Also Published As

Publication number Publication date
KR20070115945A (ko) 2007-12-06
TW200640946A (en) 2006-12-01
CN101151276A (zh) 2008-03-26
AU2006215012B8 (en) 2012-04-12
SG174827A1 (en) 2011-10-28
WO2006088198A1 (ja) 2006-08-24
KR101273001B1 (ko) 2013-06-10
US8062863B2 (en) 2011-11-22
EP2172480A2 (en) 2010-04-07
EP2172480B1 (en) 2013-08-14
CA2598570C (en) 2016-03-22
US20090011453A1 (en) 2009-01-08
JP4999677B2 (ja) 2012-08-15
JPWO2006088198A1 (ja) 2008-07-03
AU2006215012A1 (en) 2006-08-24
EP2172480A3 (en) 2010-09-08
CN101151276B (zh) 2012-10-10
CA2598570A1 (en) 2006-08-24
EP1857465A1 (en) 2007-11-21
AU2006215012B2 (en) 2012-02-09
TWI406870B (zh) 2013-09-01
EP1857465A4 (en) 2009-01-28

Similar Documents

Publication Publication Date Title
EP1901820A4 (en) PROCESS FOR REDUCING THE CONDITION OF PROTEINS RELATED TO DISEASES
EP1748077A4 (en) PROCESS FOR PROTEIN PRODUCTION
IL190550A0 (en) Methods of protein production using anti-senescence compounds
EP2035572A4 (en) PROCESS FOR THE PREPARATION OF FACTOR VIII PROTEINS BY RECOMBINATION PROCEDURES
EP1854776A4 (en) PROCESS FOR THE PRODUCTION OF OLEFINES
PL1713760T3 (pl) Sposób wytwarzania dinitryli
IL180247A0 (en) Method for producing 4-
ZA200805297B (en) Method of using ß-hydroxy-ß-methylbutyrate
HK1143608A1 (en) Method of producing heterogeneous protein
PL1969127T5 (pl) Metoda wytwarzania biologicznie czynnych białek zależnych od witaminy K metodami rekombinacji
EP1995254A4 (en) PROCESS FOR PRODUCING PEPTIDE
IL177233A0 (en) Method for producing polyisobutenylphenols
EP1932906A4 (en) PROCESS FOR PRODUCING UF BY NUCLEAR TRANSPLANTATION
PL1835816T3 (pl) Sposób wytwarzania hydrolizatów białkowych
EP2062974A4 (en) PROCESS FOR PREPARING FUSION PROTEIN
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
EP1748071A4 (en) PROCESS FOR PRODUCTION OF POLYPEPTIDE
EP1790633A4 (en) PROCESS FOR THE PREPARATION OF 2-HYDROXY-4-METHYLTHIOBUTAN ACID
PL1865784T3 (pl) Sposób wytwarzania pojedynczych porcji
EP1860069A4 (en) PROCESS FOR PREPARING A COMPOSITION
EP1878737A4 (en) METHOD OF SYNTHESIZING INDAZOLE-3-YLMETHYLPHOSPHONIUM SALT
EP1914313A4 (en) PROCESS FOR THE PRODUCTION OF CERCOSPORAMIDE
ZA200709013B (en) Method for producing 2-isopropenyl-5-methyl-4-hexen-1-yl 3-methyl-2-butenoate
EP1927590A4 (en) PROCESS FOR PREPARING A 1-SUBSTITUTED 5-ACYLIMIDAZOLE COMPOUND
EP1882743A4 (en) PROCESS FOR PRODUCING A PROTEIN

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200227